Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Clin Exp Immunol ; 146(1): 76-84, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16968401

ABSTRACT

It has been demonstrated that infections due to Shiga toxins (Stx) producing Escherichia coli are the main cause of the haemolytic uraemic syndrome (HUS). However, the contribution of the inflammatory response in the pathogenesis of the disease has also been well established. Neutrophils (PMN) represent a central component of inflammation during infections, and patients with high peripheral PMN counts at presentation have a poor prognosis. The mouse model of HUS, by intravenous injection of pure Stx type 2 (Stx2), reproduces human neutrophilia and allows the study of early events in the course of Stx2-induced pathophysiological mechanisms. The aim of this study was to address the contribution of PMN on Stx2 toxicity in a murine model of HUS, by evaluating the survival and renal damage in mice in which the granulocytic population was depleted. We found that the absence of PMN reduced Stx2-induced lethal effects and renal damage. We also investigated the mechanisms underlying Stx2-induced neutrophilia, studying the influence of Stx2 on myelopoyesis, on the emergence of cells from the bone marrow and on the in vivo migration into tissues. Stx2 administration led to an accelerated release of bone marrow cells, which egress at an earlier stage of maturation, together with an increase in the proliferation of myeloid progenitors. Moreover, Stx2-treated mice exhibited a lower migratory capacity to a local inflammatory site. In conclusion, PMN are essential in the pathogenesis of HUS and neutrophilia is not merely an epiphenomenon, but contributes to Stx2-damaging mechanism by potentiating Stx2 toxicity.


Subject(s)
Hemolytic-Uremic Syndrome/pathology , Neutrophils/physiology , Shiga Toxin 2/toxicity , Animals , Bone Marrow Cells/pathology , Chemotaxis, Leukocyte/drug effects , Disease Models, Animal , Hemolytic-Uremic Syndrome/etiology , Leukocytosis/etiology , Leukocytosis/pathology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Neutrophils/drug effects , Rabbits
2.
Medicina (B.Aires) ; 66(supl.2): 16-21, 2006. tab, ilus
Article in Spanish | BINACIS | ID: bin-123541

ABSTRACT

The central role of the immune system is the preservation of the health against several pathogenic microbes and injury agents. However, on special conditions defensive mechanisms triggered towards the foreign agent can damage the host. Clinical and experimental evidence indicate that inflammatory reaction triggered by the main components of Shiga toxin (Stx)-producing Escherichia coil (STEC), participate in the evolution to the complete form of HUS. When children are diagnosed of HUS, they present evidence that have suffered a very strong and early inflammatory response. These features include: the presence of a marked neutrophilia, the polymorfonuclear leucocytes (PMN) are "deactivated or exhausted" and the monocytes are differentiated towards an inflammatory phenotype (CD14-reduced and CD16-enhanced membrane expression). In addition, HUS-patients show a marked reduction in the absolute and relative number of leucocytes carrying the receptor (CX3CR1) for the chemokine "Fractalkine" (FKN, CX3CL1), which are the classic monocytes and Natural Killer cells (NK). All these cells express a high cytotoxic potencial. The chemokine FKN is expressed in endothelial and epithelial renal cells, and is involved in the pathogenic mechanism of different nephropathies. Noteworthy, we found a significant correlation between the severity of the renal damage (as days of anuria) and the alterations described above. Finally, the protective role of specific immune response, mainly through the antibody production with Stx-neutralizing capacity, is discussed.(AU)


Subject(s)
Humans , Animals , Rats , Hemolytic-Uremic Syndrome/immunology , Immunity, Innate/immunology , Shiga Toxin/toxicity , Neutrophil Activation/immunology , Antigens, CD/immunology , Chemokines, CX3C/immunology , Escherichia coli/immunology , Escherichia coli/pathogenicity , Escherichia coli Infections/immunology , Fibroblast Growth Factors/immunology , Hemolytic-Uremic Syndrome/therapy , Killer Cells, Natural/immunology , Murinae , Neutrophils/immunology , Renal Dialysis , Shiga Toxin/antagonists & inhibitors , Shiga Toxin/immunology , Cytokines/immunology , Disease Models, Animal
3.
Medicina (B.Aires) ; 66(supl.2): 16-21, 2006. tab, ilus
Article in Spanish | LILACS | ID: lil-480133

ABSTRACT

The central role of the immune system is the preservation of the health against several pathogenic microbes and injury agents. However, on special conditions defensive mechanisms triggered towards the foreign agent can damage the host. Clinical and experimental evidence indicate that inflammatory reaction triggered by the main components of Shiga toxin (Stx)-producing Escherichia coil (STEC), participate in the evolution to the complete form of HUS. When children are diagnosed of HUS, they present evidence that have suffered a very strong and early inflammatory response. These features include: the presence of a marked neutrophilia, the polymorfonuclear leucocytes (PMN) are "deactivated or exhausted" and the monocytes are differentiated towards an inflammatory phenotype (CD14-reduced and CD16-enhanced membrane expression). In addition, HUS-patients show a marked reduction in the absolute and relative number of leucocytes carrying the receptor (CX3CR1) for the chemokine "Fractalkine" (FKN, CX3CL1), which are the classic monocytes and Natural Killer cells (NK). All these cells express a high cytotoxic potencial. The chemokine FKN is expressed in endothelial and epithelial renal cells, and is involved in the pathogenic mechanism of different nephropathies. Noteworthy, we found a significant correlation between the severity of the renal damage (as days of anuria) and the alterations described above. Finally, the protective role of specific immune response, mainly through the antibody production with Stx-neutralizing capacity, is discussed.


Subject(s)
Humans , Animals , Rats , Hemolytic-Uremic Syndrome/immunology , Immunity, Innate/immunology , Neutrophil Activation/immunology , Shiga Toxin/toxicity , Antigens, CD/immunology , /immunology , Cytokines/immunology , Disease Models, Animal , Escherichia coli Infections/immunology , Escherichia coli/immunology , Escherichia coli/pathogenicity , Fibroblast Growth Factors/immunology , Hemolytic-Uremic Syndrome/therapy , Killer Cells, Natural/immunology , Murinae , Neutrophils/immunology , Renal Dialysis , Shiga Toxin/antagonists & inhibitors , Shiga Toxin/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...